22.32 USD
▼-0.76-3.29%
盘后 22.34 +0.09%
2026-09-15
市值
$1.30B
市盈率
1.09
EPS
20.19
股息率
—
52 周区间
6.50 – 49.95
成交量
729.84K
Beta
1.72
目标价
39.00
52W 低 6.5052W 高 49.95
价格走势
公司简介
Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren’s disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and...